Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$3.74 USD
-0.23 (-5.79%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.74 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Fundamental Charts
About Return on Equity (TTM)
Aveanna Healthcare Holdings Inc.'s return on equity, or ROE, is -15.16% compared to the ROE of the Medical - Outpatient and Home Healthcare industry of 7.89%. While this shows that AVAH has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
AVAH 3.74 -0.23(-5.79%)
Will AVAH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVAH
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health to Expand Florida Presence With New 50-bed Facility
Other News for AVAH
Aveanna Healthcare Holdings Improving Performance In High-Demand Sector
This Keysight Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
Jefferies Upgrades Aveanna Healthcare (AVAH) Despite Lowered Price Target | AVAH Stock News
Aveanna (AVAH) Receives Upgrade from Jefferies, Boosting Investor Confidence | AVAH Stock News
Aveanna just upgraded at Jefferies, here's why